Fund Holdings — 5AM Venture Management, LLC

Total Portfolio Value:
$273.05M
Total Bought:
$13.77M
Total Sold:
$50.84M
Net Transaction:
-$37.08M
Notable People:
Anna Cosslett Yaeger
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Skye Bioscience, Inc.(SKYE)9,913,1689,681,763-231,405$41.44M$38.05M13.94%-$3.39M
Entrada Therapeutics, Inc.(TRDA)4,308,3794,256,379-52,000$28.95M$24.69M9.04%-$4.27M
Pharvaris N V
COM
797,600797,6000$14.04M$19.90M7.29%+$5.86M
CAMP4 THERAPEUTICS CORPORATION(CAMP)2,927,9155,869,091+2,941,176$4.25M$17.61M6.45%+$13.36M
Centessa Pharmaceuticals PlcADS830,945680,945-150,000$10.92M$16.51M6.05%+$5.59M
Viridian Therapeutics, Inc.(VRDN)736,595736,5950$10.30M$15.90M5.82%+$5.60M
Enliven Therapeutics Inc772,477772,4770$15.50M$15.81M5.79%+$316.7K
EyePoint, Inc.(EYPT)1,050,0001,050,0000$9.88M$14.95M5.48%+$5.07M
Dianthus Therapeutics, Inc.(DNTH)984,725365,053-619,672$18.35M$14.36M5.26%-$3.98M
Tyra Biosciences, Inc.(TYRA)939,298939,2980$8.99M$13.14M4.81%+$4.15M
Celldex Therapeutics, Inc.(CLDX)497,270497,2700$10.12M$12.86M4.71%+$2.74M
Erasca, Inc.(ERAS)5,405,4045,405,4040$6.86M$11.78M4.32%+$4.92M
Praxis Precision Medicines, Inc.(PRAX)170,000170,0000$7.15M$9.01M3.30%+$1.86M
GH Research PLC(GHRS)572,665572,6650$6.98M$8.19M3.00%+$1.21M
Tectonic Therapeutic, Inc.(TECX)511,660511,6600$10.17M$8.03M2.94%-$2.14M
Biohaven Ltd.(BHVN)478,972478,9720$6.76M$7.19M2.63%+$431.1K
Artiva Biotherapeutics, Inc.(ARTV)2,353,3042,353,3040$3.55M$6.75M2.47%+$3.20M
Surrozen, Inc.(SRZN)310,000310,0000$2.77M$3.99M1.46%+$1.22M
Protara Therapeutics, Inc.(TARA)800,000800,0000$2.42M$3.48M1.27%+$1.06M
Alector Inc995,841995,8410$1.39M$2.95M1.08%+$1.55M
Silence Therapeutics plcADS(SLN)476,200476,2000$2.76M$2.47M0.91%-$290.5K
Adverum Biotechnologies Inc541,666541,6660$1.16M$2.45M0.90%+$1.29M
Rallybio Corporation(RLYB)3,630,7243,630,7240$1.23M$1.81M0.66%+$584.5K
Zentalis Pharmaceuticals, Inc.(ZNTL)490,000490,0000$568.4K$739.9K0.27%+$171.5K
Mersana Therapeutics Inc052,200+52,200$0$405.1K0.15%+$405.1K
Mersana Therapeutics Inc1,305,0000-1,305,000$386.3K$0—-$386.3K
MoonLake ImmunotherapeuticsCL A(MLTX)282,3130-282,313$13.33M$0—-$13.33M
Scpharmaceuticals Inc1,200,6470-1,200,647$4.57M$0—-$4.57M
Viking Therapeutics, Inc.(VKTX)189,5930-189,593$5.02M$0—-$5.02M
Vor Biopharma Inc.(VOR)6,361,7230-6,361,723$10.31M$0—-$10.31M
Page 1 of 1
5AM Venture Management, LLC — 13F Holdings — Q3 2025 | TickerTrail